Tag: investment
-
Nanotech Gene Therapy Company Raises $8.5M in Seed Funds
A start-up company developing nanoscale particles to deliver gene-editing enzymes, including those for Crispr, is raising $8.5 million in its seed funding round.
-
RNA Biotech Raises $604M in IPO
Moderna Therapeutics, a biotechnology enterprise developing therapies with synthetic RNA, issued its initial public stock offering, or IPO, on Thursday, raising more than $604 million.
-
Janssen Licensing Cancer Antibodies in $1.8B Deal
An affiliate of drug maker Janssen Pharmaceutical is licensing a synthetic antibody to treat blood-related cancers from a developer of antibodies based on the immune system of llamas.
-
Investing In Science And Tech – What You Need To Know
If you think that these are the best sectors for you to invest in right now, these following tips should help you get started.
-
What Are Ways To Invest Your Money?
Here are some of the best ways to invest your money and hopefully make a tidy bit of profit,
-
RNA Therapeutics Company Raises $30M in First Venture Round
A company spun-off from a university biochemistry lab is raising $30 million to fund discovery of treatments targeting RNA, genetic material instructing protein production in cells.
-
Trial Underway for Inhaled Heart Rhythm Drug, Developer Raises $42M
A clinical trial is underway testing an inhaled therapy to quickly treat irregular heart rhythms, in cases where the problems occur occasionally and often resolve on their own.
-
Synthetic DNA Company Raising $70 Million in IPO
A 5 year-old enterprise developing synthetic DNA for medical and agricultural chemicals, as well as data storage, is raising $70 million in its initial public stock offering.
-
Gene Silencing Technology Licensed in $3.7B Deal
Dicerna Pharmaceuticals, developing treatments for disease that silence genes by interfering with their RNA instructions, is licensing its technology to drug maker Eli Lilly and Co
-
Start-Up Developing Immunometabolism Therapies, Gains $30M Funding
A start-up enterprise founded by medical researchers in the U.S. and Europe is developing treatments for cancer and autoimmune disorders that change chemical reactions in immune system cells.